Company / Working Capital
BioRestorative Therapies, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$586.0K
FY2025
5-year range
-$586.0K / $21.1M
FY2021-FY2025
Trend
-107.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 4 consecutive years, from $21M in FY2021 to -$586,029 in FY2025.
Based on SEC 10-K filings.
-$586,029 in FY2025.
Declined from $9M to -$586,029 over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s working capital has declined for 4 consecutive years.
- In FY2025, working capital decreased 107.9% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$586.0K | -107.9% |
| FY2024 | $7.4M | -15.8% |
| FY2023 | $8.8M | -40.2% |
| FY2022 | $14.7M | -30.4% |
| FY2021 | $21.1M | +885.1% |
| FY2020 | $2.1M | +115.7% |
| FY2019 | -$13.7M | -50.5% |
| FY2018 | -$9.1M | -15.8% |
| FY2017 | -$7.8M | -35.5% |
| FY2016 | -$5.8M | -8.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026